Literature DB >> 2125408

Decreased fibrinolytic activity in juvenile chronic arthritis.

L Mussoni1, G Pintucci, G Romano, F De Benedetti, M Massa, A Martini.   

Abstract

The basal fibrinolytic activity in 17 children with active juvenile chronic arthritis (JCA) was investigated. It was found that patients with JCA, and particularly those with the systemic form, show decreased plasma fibrinolytic activity and a marked increase in plasminogen activator inhibitor. Additionally, it was found that patients with systemic JCA, but not those with the polyarticular or pauciarticular form, have increased circulating levels of tissue-type plasminogen activator, and endothelial cell protein, suggesting possible endothelial cell participation in systemic JCA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125408      PMCID: PMC1004289          DOI: 10.1136/ard.49.12.973

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

Review 1.  Plasminogen activator inhibitors.

Authors:  E D Sprengers; C Kluft
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

2.  Defective fibrinolytic response in atherosclerotic patients--effect of iloprost and its possible mechanism of action.

Authors:  V Bertelé; L Mussoni; G del Rosso; G Pintucci; M R Carriero; M G Merati; A Libretti; G de Gaetano
Journal:  Thromb Haemost       Date:  1988-10-31       Impact factor: 5.249

Review 3.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

Review 4.  On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.

Authors:  D Collen
Journal:  Thromb Haemost       Date:  1980-06-18       Impact factor: 5.249

5.  Increased blood fibrinolytic activity after aspirin ingestion.

Authors:  L A Moroz
Journal:  N Engl J Med       Date:  1977-03-10       Impact factor: 91.245

6.  Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis.

Authors:  E D Silverman; J J Miller; B Bernstein; T Shafai
Journal:  J Pediatr       Date:  1983-12       Impact factor: 4.406

7.  Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection.

Authors:  M Hadchouel; A M Prieur; C Griscelli
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

8.  Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.

Authors:  I M Nilsson; H Ljungnér; L Tengborn
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

9.  Low dose aspirin does not prevent fibrinolytic response to venous occlusion.

Authors:  G de Gaetano; M R Carriero; C Cerletti; L Mussoni
Journal:  Biochem Pharmacol       Date:  1986-09-15       Impact factor: 5.858

10.  Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells.

Authors:  D D Wagner; J B Olmsted; V J Marder
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  3 in total

1.  Endothelial cell derived factors in relation to antibodies to SSA or SSB and to endothelial cells in Sjögren's syndrome.

Authors:  S Rantapää-Dahlqvist; T K Nilsson
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

2.  Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.

Authors:  S Wållberg-Jonsson; G H Dahlén; T K Nilsson; M Rånby; S Rantapää-Dahlqvist
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

3.  Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis.

Authors:  Bradley J Bloom; Mieko Toyoda; Anna Petrosian; Stanley Jordan
Journal:  Rheumatol Int       Date:  2006-12-13       Impact factor: 3.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.